Clinical Trial Update: Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating resveratrol for glycemic variability in adults with Type 2 Diabetes Mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Guadalajara | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED